Brenda C. O'Connell PhD

Infinity Pharmaceuticals, Inc

Appearances

Targeting PI3K-gamma with IPI-549, a Tumor Macrophage-Reprogramming Small Molecule, in Patients with Advanced Solid Tumors
Date
September 23, 2020
Speaker
Brenda C. O'Connell, PhD
Infinity Pharmaceuticals, Inc

Privacy Policy Update: We value your privacy and want you to understand how your information is being used. To make sure you have current and accurate information about this sites privacy practices please visit the privacy center by clicking here.

Brenda C. O'Connell PhD

Infinity Pharmaceuticals, Inc

Appearances

Targeting PI3K-gamma with IPI-549, a Tumor Macrophage-Reprogramming Small Molecule, in Patients with Advanced Solid Tumors

Speaker